Giant Biogene Holding Co., Ltd.
2367.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$25.33B
Close$
Share Statistics
| Market cap | $25.33 Billion |
|---|---|
| Enterprise Value | $20.55 Billion |
| Dividend Yield | $2.70 (5.82%) |
| Earnings per Share | $1.83 |
| Beta | 0.75 |
| Outstanding Shares | 1,050,117,000 |
Return
| Return on Equity | 41.90% |
|---|---|
| Return on Assets | 38.28% |
| Return on Invested Capital | 44.67% |
Valuation & Multiples
| P/E Ratio | 13.02 |
|---|---|
| PEG | -60.28 |
| Price to Sales | 2.31 |
| Price to Book Ratio | 2.89 |
| Enterprise Value to Revenue | 1.8 |
| Enterprise Value to EBIT | 4.86 |
| Enterprise Value to Net Income | 5 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 18, 2026
EPS Estimate
$1.02
Average shareholder expectationRevenue Estimate
$3.34 B
Average shareholder expectationNext Earnings Call
Expected Date
March 29, 2027
EPS Estimate
$1.03
Average shareholder expectationRevenue Estimate
$3.68 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Giant Biogene Holding Co., Ltd.
2,319 employees
CEO: Jianya Yan Giant Biogene Holding Co., Ltd. operates as an investment holding entity, primarily engaged in the research, development, production, and sale of beauty and wellness products based on bioactive materials throughout the People's Republic ...